TCT-30 PREMIUM Trial: Double blind study of percutaneous closure of patent foramen ovale with the AMPLATZER® PFO Occluder as a treatment for migraine with or without aura

Jonathan M. Tobis(University of California, Irvine), John C. Gurley(University of Kentucky), Brij Maini(Delray Medical Center), Stephen D. Silberstein(Thomas Jefferson University), Sherman G. Sorensen(Intermountain Medical Center), Phillip A. Horwitz(University of Iowa), Andrew Charles(University of California, Los Angeles)
Journal of the American College of Cardiology
October 1, 2015
Cited by 9


Related Papers